FIBROGEN INC's ticker is FGEN and the CUSIP is 31572Q808. A total of 194 filers reported holding FIBROGEN INC in Q1 2020. The put-call ratio across all filers is 1.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $12,492 | -62.0% | 14,000 | 0.0% | 0.00% | -50.0% |
Q1 2024 | $32,900 | +165.2% | 14,000 | 0.0% | 0.00% | +100.0% |
Q4 2023 | $12,408 | +2.7% | 14,000 | 0.0% | 0.00% | 0.0% |
Q3 2023 | $12,081 | -68.0% | 14,000 | 0.0% | 0.00% | -60.0% |
Q2 2023 | $37,800 | -86.5% | 14,000 | -6.7% | 0.01% | -88.4% |
Q1 2023 | $279,900 | +16.5% | 15,000 | 0.0% | 0.04% | +10.3% |
Q4 2022 | $240,300 | +23.2% | 15,000 | 0.0% | 0.04% | +18.2% |
Q3 2022 | $195,000 | +22.6% | 15,000 | 0.0% | 0.03% | +26.9% |
Q2 2022 | $159,000 | -11.7% | 15,000 | 0.0% | 0.03% | +8.3% |
Q1 2022 | $180,000 | -14.7% | 15,000 | 0.0% | 0.02% | -11.1% |
Q4 2021 | $211,000 | +37.9% | 15,000 | 0.0% | 0.03% | +28.6% |
Q3 2021 | $153,000 | -61.8% | 15,000 | 0.0% | 0.02% | -60.4% |
Q2 2021 | $400,000 | -23.2% | 15,000 | 0.0% | 0.05% | -28.4% |
Q1 2021 | $521,000 | +56.0% | 15,000 | +66.7% | 0.07% | +42.3% |
Q4 2020 | $334,000 | -9.7% | 9,000 | 0.0% | 0.05% | -21.2% |
Q3 2020 | $370,000 | +1.4% | 9,000 | 0.0% | 0.07% | -4.3% |
Q2 2020 | $365,000 | +16.6% | 9,000 | 0.0% | 0.07% | -4.2% |
Q1 2020 | $313,000 | -18.9% | 9,000 | 0.0% | 0.07% | +9.1% |
Q4 2019 | $386,000 | +15.9% | 9,000 | 0.0% | 0.07% | +8.2% |
Q3 2019 | $333,000 | +22.9% | 9,000 | +50.0% | 0.06% | +24.5% |
Q2 2019 | $271,000 | -16.9% | 6,000 | 0.0% | 0.05% | -16.9% |
Q1 2019 | $326,000 | +41.1% | 6,000 | +20.0% | 0.06% | +22.9% |
Q4 2018 | $231,000 | +7.4% | 5,000 | +25.0% | 0.05% | +23.1% |
Q3 2017 | $215,000 | -53.7% | 4,000 | -72.1% | 0.04% | -55.7% |
Q2 2017 | $464,000 | +31.1% | 14,352 | 0.0% | 0.09% | +31.3% |
Q1 2017 | $354,000 | +15.3% | 14,352 | 0.0% | 0.07% | +9.8% |
Q4 2016 | $307,000 | +3.4% | 14,352 | 0.0% | 0.06% | 0.0% |
Q3 2016 | $297,000 | +25.8% | 14,352 | 0.0% | 0.06% | +22.0% |
Q2 2016 | $236,000 | -25.8% | 14,352 | 0.0% | 0.05% | -26.5% |
Q1 2016 | $318,000 | -27.2% | 14,352 | 0.0% | 0.07% | -24.4% |
Q4 2015 | $437,000 | +38.7% | 14,352 | 0.0% | 0.09% | +32.4% |
Q3 2015 | $315,000 | – | 14,352 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EcoR1 Capital, LLC | 1,735,677 | $93,379,000 | 12.44% |
Omega Fund Management, LLC | 314,348 | $16,912,000 | 9.57% |
Opaleye Management Inc. | 360,000 | $19,368,000 | 6.85% |
NEXTHERA CAPITAL LP | 217,329 | $11,692,000 | 3.01% |
Monashee Investment Management LLC | 122,300 | $6,580,000 | 2.49% |
Hillhouse Capital Management | 2,486,196 | $133,757,000 | 2.21% |
DOHENY ASSET MANAGEMENT /CA | 50,925 | $2,740,000 | 1.26% |
Sicart Associates LLC | 31,072 | $1,672,000 | 1.20% |
Iguana Healthcare Management, LLC | 80,000 | $4,304,000 | 1.19% |
Rhenman & Partners Asset Management AB | 145,500 | $7,828,000 | 1.00% |